News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

This article was first published 3 years ago
Home  » News » Sameer Wankhede's eventful NCB stint to end on Dec 31

Sameer Wankhede's eventful NCB stint to end on Dec 31

Source: PTI   -  Edited By: Senjo M R
December 17, 2021 21:53 IST
Get Rediff News in your Inbox:

The tenure of Indian Revenue Service officer Sameer Wankhede with the Narcotics Control Bureau, which was marked by controversy, would end on December 31, official sources said on Friday.

IMAGE: NCB officer Sameer Wankhede. Photograph: ANI Photo

Wankhede, a 2008-batch Indian Revenue Service officer, was on deputation to the NCB since September 2020 and is currently Mumbai zonal director of the anti-drugs agency.

 

He was earlier posted with the Directorate of Revenue Intelligence.

As zonal director of NCB, Wankhede was involved in action against the drug syndicates allegedly involving Bollywood celebrities in the aftermath of actor Sushant Singh Rajput's death by suicide.

In October this year, a team led by Wankhede allegedly recovered drugs during a raid on a cruise ship off the Mumbai coast, and arrested actor Shah Rukh Khan's son Aryan along with others.

But subsequently questions were raised about the credentials of independent witnesses used by the NCB during the raid, and it was also alleged that there was an attempt to extort money from Shah Rukh Khan by NCB officials.

Maharashtra minister Nawab Malik targeted Wankhede, alleging that he was born a Muslim but got his job in the Scheduled Castes quota by obtaining a bogus caste certificate.

Wankhede denied the allegation and his father filed a defamation suit against Malik, an Nationalist Congress Party leader.

It is not yet clear where he would be posted after his NCB deputation ends, sources said.

Get Rediff News in your Inbox:
Source: PTI  -  Edited By: Senjo M R© Copyright 2024 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.